RS151154986 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (13)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| X-21343 levels | A | OR: 0.48 | 4E-64 | PubMed |
| X-22764 levels | A | OR: 0.47 | 2E-61 | PubMed |
| Dodecadienoate (12:2) (X-21343) levels | A | OR: 0.59 | 9E-47 | PubMed |
| Dodecadienoate (12:2) levels | A | OR: 0.6 | 1E-43 | PubMed |
| Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid (X-22764) levels | A | OR: 0.53 | 4E-36 | PubMed |
| Undecenoylcarnitine (C11:1) levels | A | OR: 0.49 | 3E-28 | PubMed |
| Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid levels | A | OR: 0.48 | 5E-28 | PubMed |
| Dodecadienoate (12:2) levels | A | OR: 1.06 | 1E-24 | PubMed |
| Plasma dodecadienoate (12:2)* levels in chronic kidney disease | A | OR: 0.45 | 6E-23 | PubMed |
| Branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid levels | A | OR: 0.88 | 2E-17 | PubMed |
| Plasma branched-chain, straight-chain, or cyclopropyl 12:1 fatty acid* levels in chronic kidney disease | A | OR: 0.54 | 1E-16 | PubMed |
| (2 or 3)-decenoate (10:1n7 or n8) levels | A | OR: 0.35 | 7E-15 | PubMed |
| (2 or 3)-decenoate (10:1n7 or n8) levels | A | OR: 0.68 | 6E-11 | PubMed |